Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathyKaren Sliwa, John J.V. McMurray, Dirk J. van Veldhuisen et al.|European Journal of Heart Failure|2010Cited by 1.1k
Levosimendan: Molecular mechanisms and clinical implicationsZoltán Papp, Ferenc Folláth, István Édes et al.|International Journal of Cardiology|2011Cited by 313
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Gilles W. De Keulenaer, Javed Butler et al.|European Heart Journal|2019Cited by 258
Treatments targeting inotropyChristoph Maack, Alexandre Mebazaa, Thomas Eschenhagen et al.|European Heart Journal|2018Cited by 227
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Journal of Cardiovascular Pharmacology|2020Cited by 111